Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines 04/19/2021 Health News
Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine 03/04/2021 Health News
